Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2014
10/30/2014US20140323418 Selective kinase inhibitors
10/30/2014US20140322247 Cell proliferation inhibitors and conjugates thereof
10/30/2014US20140322195 Factor IXA Inhibitors
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871937 8-hydroxy-quinoline derivatives
10/28/2014US8871930 Preparation method of alpha-imatinib mesylate
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871792 Neprilysin inhibitors
10/28/2014US8871785 Antiviral phosphonate analogs
10/28/2014US8871778 Substituted pyrimidine compounds and their use as SYK inhibitors
10/28/2014US8871770 Carboxamide compounds and methods for using the same
10/28/2014US8871766 Heterocyclic compounds
10/28/2014US8871759 Inhibitors of hepatitis C virus replication
10/28/2014US8871756 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/28/2014US8871747 Urea and thiourea derivatives
10/28/2014US8871718 Transglutaminase inhibitors and methods of use thereof
10/23/2014US20140316131 Process for manufacturing triazinon-benzoxazinones
10/23/2014US20140315966 Isoxazole Treatments for Diabetes
10/23/2014US20140315963 Heterocyclic acetamide compound
10/23/2014US20140315962 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
10/23/2014US20140315946 Nonpeptide hiv-1 protease inhibitors
10/23/2014US20140315928 Substituted amide compounds
10/23/2014US20140315917 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315904 Arginine methyltransferase inhibitors and uses thereof
10/23/2014US20140315903 1, 4-Disubstituted 3-Cyano-Pyridone Derivatives and Their Use As Positive Allosteric Modulators of MGLUR2-Receptors
10/23/2014US20140315886 Quinazolines as therapeutic compounds and related methods of use
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315882 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof
10/23/2014US20140315881 Compounds and methods
10/23/2014US20140315856 Aminopyrazole derivative
10/23/2014US20140315721 Pesticidal compositions and processes related thereto
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/21/2014US8865912 Benzimidazole derivatives as PI3 kinase inhibitors
10/21/2014US8865900 Methyltetrazole sulfides and sulfones
10/21/2014US8865896 Method for preparing adenine compound
10/21/2014US8865894 Oxazolidin-2-one compounds and uses thereof
10/21/2014US8865744 (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
10/21/2014US8865739 Substituted heterocyclic compounds as ion channel modulators
10/21/2014US8865738 5-membered heterocyclic compound cyclopenta[C]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865717 Heterocyclic compounds
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/21/2014US8865712 Heterocyclic derivatives and their use in the treatment of neurological disorders
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865707 Cholesteryl ester transfer protein inhibitors
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865701 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
10/21/2014US8865682 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
10/21/2014US8865623 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/16/2014US20140309427 Substituted Pyran Derivatives
10/16/2014US20140309238 Fluoralkylcarbonyl-oxadiazoles
10/16/2014US20140309231 Nitrogen-containing heterocyclic compounds
10/16/2014US20140309227 QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
10/16/2014US20140309226 Piperidinyl-substituted cyclic ureas as gpr119 modulators
10/16/2014US20140309225 Novel nicotinamide derivative or salt thereof
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859765 Process for the manufacture of chiral catalysts and their salts
10/14/2014US8859602 Inhibitors of c-fms kinase
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859595 Potent and selective inhibitors of hepatitis C virus
10/14/2014US8859592 Insecticidal compounds
10/14/2014US8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859547 Pyridazinone derivatives
10/14/2014US8859546 Picolinamide inhibitors of kinases
10/14/2014US8859545 Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859535 Hydroxy substituted isoquinolinone derivatives
10/14/2014US8859534 2-carboxamide-7-piperazinyl-benzofuran derivatives
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859113 Carbazole derivatives and organic light-emitting diode device using the same
10/14/2014US8859108 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014165075A1 Antibacterial agents
10/09/2014WO2014165065A1 Substituted piperidine compounds and their use as orexin receptor modulators
10/09/2014WO2014164648A2 Solid state forms of a quinazoline derivative and its use as a braf inhibitor
10/09/2014WO2014164596A1 Bet bromodomain inhibitors and therapeutic methods using the same
10/09/2014WO2014163162A1 Heterocyclic compound
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014161808A1 Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]jpyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors
10/09/2014WO2014161516A1 Oxa- and thia-diazoles useful in the treatment of tuberculosis
10/09/2014US20140303376 Class of near infrared molecular probes for biological applications
10/09/2014US20140303182 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/09/2014US20140303171 Hiv protease inhibitors
10/09/2014US20140303156 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303151 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
10/09/2014US20140303139 Pyrimidines as sodium channel blockers
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 647